Table 3.
Antibiotic profile of resistant enteric isolates obtained (N=198)
| nAB | Antibiotic resisted | Rate n (%) |
|---|---|---|
|
| ||
| 10 | AMP, AMC, CFX, AZT, CPX, IMP, CTX, TET, CFZ, GN | 7 (3.5) |
| 9 | AMP, AMC, CFX, AZT, CPX, IMP, CTX, TET, CFZ | 7 (3.5) |
| 8 | AMP, AMC, CFX, AZT, CPX, IMP, CTX, TET | 14 (7.1) |
| 8 | AMP, AMC, CFX, AZT, CPX, IMP, CTX, CFZ | 12 (6.1) |
| 6 | AMP, AMC, CFX, AZT, CPX, IMP | 10 (5.1) |
| 5 | AMP, AMC, CFX, AZT, CPX | 17 (8.6) |
| 4 | AMP, AMC, CFX, AZT | 11 (5.6) |
| 8 | AMP, AMC, CFX, CTX, IMP, CFZ, TET, CFZ | 30 (15.2) |
| 3 | AMP, AMC, CFZ | 34 (17.2) |
| 3 | AMP, CFX, CTX | 56 (28.3) |
Abbreviations: %, percentage resisted; AMC, amoxicillin/clavulanate; AMP, Ampicillin; AZT, azithromycin; CFX, cefuroxime; CFZ, ceftazidime; CPX, ciprofloxacin; CTX, cefotaxime; GN, gentamycin; IMP, imipenem; nAB, number of antibiotics resisted with MIC >32 µg/mL; TET, tetracycline.